Article info

Download PDFPDF

Evaluation of dosing strategy for pembrolizumab for oncology indications

Authors

  1. a tomoko.freshwater{at}merck.com
  2. b anna.kondic{at}merck.com
  3. c malidi.ahamadi{at}merck.com
  4. d claire.li{at}merck.com
  5. e rdegreef{at}wequantify.com
  6. f dinesh.de.alwis{at}merck.com
  7. g 267-305-5705 julie_stone{at}merck.com
View Full Text

Citation

Freshwater T, Kondic A, Ahamadi M, et al
Evaluation of dosing strategy for pembrolizumab for oncology indications

Publication history

  • Received September 15, 2016
  • Accepted April 26, 2017
  • First published May 16, 2017.
Online issue publication 
May 16, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.